Nanotechnology-based drug delivery for the treatment of CNS disorders

Abstract

Approximately 6.8 million people die annually because of problems related to the central nervous system (CNS), and out of them, approximately 1 million people are affected by neurodegenerative diseases that include Alzheimer’s disease, multiple sclerosis, epilepsy, and Parkinson’s disease. CNS problems are a primary concern because of the complexity of the brain. There are various drugs available to treat CNS disorders and overcome problems with toxicity, specificity, and delivery. Barriers like the blood–brain barrier (BBB) are a challenge, as they do not allow therapeutic drugs to cross and reach their target. Researchers have been searching for ways to allow drugs to pass through the BBB and reach the target sites. These problems highlight the need of nanotechnology to alter or manipulate various processes at the cellular level to achieve the desired attributes. Due to their nanosize, nanoparticles are able to pass through the BBB and are an effective alternative to drug administration and other approaches. Nanotechnology has the potential to improve treatment and diagnostic techniques for CNS disorders and facilitate effective drug transfer. With the aid of nanoengineering, drugs could be modified to perform functions like transference across the BBB, altering signaling pathways, targeting specific cells, effective gene transfer, and promoting regeneration and preservation of nerve cells. The involvement of a nanocarrier framework inside the delivery of several neurotherapeutic agents used in the treatment of neurological diseases is reviewed in this study.

Point biserial correlation symbiotic organism search nanoengineering based drug delivery for tumor diagnosis

“…Disorders in the central nervous system and the issues related to focusing the drug delivery were analyzed in 18 . Existing methods combining machine learning (ML) into molecular dynamic simulation though improved the overall procedure.…”

Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective

“…As a result, transit likely involves all cells. Consequently, lipid-soluble compounds can pass freely through all endothelial membranes and easily cross the BBB [ 61 ]. Various different strategies are mentioned in recent studies, including direct injection, nose-to-brain route, the opening of BBB, inhibition of efflux transporters, and use of nanocarrier [ 62 ]; however, among these strategies, nanocarrier seems to be the most appropriate and result-oriented.…”

Drug delivery methods based on nanotechnology for the treatment of eye diseases

“…Nevertheless, similar to every medical intervention, there exist possible problems and obstacles linked to this particular method. Several challenges arise when considering the application of nanotechnology-based medication delivery systems for the treatment of ocular disorders, including 97 , 98 .…”